Viewing Study NCT05025592


Ignite Creation Date: 2025-12-24 @ 3:56 PM
Ignite Modification Date: 2026-02-02 @ 10:03 AM
Study NCT ID: NCT05025592
Status: UNKNOWN
Last Update Posted: 2021-09-02
First Post: 2021-08-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: cTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1 Antibody for uHCC
Sponsor: Peking University Cancer Hospital & Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HCC View
None Transarterial Chemoembolization View
None Hepatic Arterial Infusion Chemotherapy View
None Regorafenib View
Keywords: